Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
STA Pharmaceutical
STA Pharmaceutical
X
LinkedIn
Trending Articles
AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme
The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
Pfizer's haemophilia A/B therapeutic Hympavzi gains FDA approval
The pharma giant's once-weekly injectable can be administered subcutaneously and is able to significantly reduce annualised bleeding
Achieving sustainable oligonucleotide production at an industrial scale
Sustainability is becoming increasingly important in pharmaceutical manufacturing, so Bachem's Philipp Markolin shares some insight into planet-friendly peptide and...
The rise of small molecule enzyme substrates in microbiology
From bacterial detection to disease diagnostics, small molecule enzyme substrates are revolutionising the pharmaceutical industry
Alleo and Ubiquigent enter AI-driven strategic partnership to accelerate DUB-focused drug discovery
Collaboration will combine Alleo’s AI-based platform with Ubiquigent’s expertise in the DUB space to advance DUB-focused preclinical programmes
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Manufacturing Chemist Live: Day One Review
The first day of MC Live has now concluded, with attendees enjoying presentations from STA Pharmaceuticals, NSF International and Lonza, among others
Manufacturing
Process optimisation with biocatalysis
From route scouting, screening and scale-up to commercial production, Dr Jingyang Zhu, VP Process Chemistry Enabling Technologies at WuXi, discusses the services and capabilities of a modern CDMO
Manufacturing
Process optimisation with flow chemistry
WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more cost-effective technologies and expedite their time to market
Drug Delivery
BioLingus partnership boosts WuXi STA’s solid dose potential
The collaboration will use BioLingus' technology to focus on sublingual and buccal drug delivery
Subscribe now